The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.
References
Link | Resource |
---|---|
https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02 | Third Party Advisory US Government Resource |
Configurations
History
25 Oct 2023, 13:39
Type | Values Removed | Values Added |
---|---|---|
References | (MISC) https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02 - Third Party Advisory, US Government Resource | |
CVSS |
v2 : v3 : |
v2 : unknown
v3 : 6.1 |
CWE | CWE-79 | |
CPE | cpe:2.3:a:dexma:dexgate:20130114:*:*:*:*:*:*:* | |
First Time |
Dexma
Dexma dexgate |
19 Oct 2023, 19:36
Type | Values Removed | Values Added |
---|---|---|
New CVE |
Information
Published : 2023-10-19 19:15
Updated : 2024-02-28 20:33
NVD link : CVE-2023-40153
Mitre link : CVE-2023-40153
CVE.ORG link : CVE-2023-40153
JSON object : View
Products Affected
dexma
- dexgate
CWE
CWE-79
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')